P/E Ratio Insights for AstraZeneca - Benzinga
4 hours ago • Google News
AstraZeneca PLC ADR (AZN)
US$ 67.72-1.78%
Price Chart
Key Statistics
Market Cap
$ 211.58B
P/E Ratio
27.20
Revenue (TTM)
$ 54.98B
Volume
4.74M
52W High
$ 86.46
52W Low
$ 61.24
Dividend Yield
2.29%
Beta
0.18
Technicals
50-Day MA
71.6272
200-Day MA
73.2371
52 Week High
86.4638
52 Week Low
61.24
About AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso.
Employees
94300
Headquarters
Cambridge, United Kingdom
CEO
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Latest News
AstraZeneca (AZN) and Other Biotech Firms Consider Relocating Tr - GuruFocus
10 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg